Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peiwen Ma

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Heliyon|April 22, 2024
Pan-cancer analysis of polo-like kinase family genes reveals polo-like kinase 1 as a novel oncogene in kidney renal papillary cell carcinomaGuo Zhao, Yuning Wang, Jiawei Zhou, et al.
Cancer Letters|June 14, 2024
First report: PLATFORM study for precision treatment of rare tumors in ChinaJiawei Zhou, Peiwen Ma, Yale Jiang, et al.
Cancer Immunology, Immunotherapy : CII|July 6, 2026
Safety and feasibility of 5T4 antibody-coupled allogeneic NK cell therapy for solid tumors: a first-in-human phase 1 trialLiangjie Sun, Peiwen Ma, Zhenwei Miao, et al.
Food Science & Nutrition|October 27, 2025
Assessment of Essential Nutrients, Bioactive Compounds, and Antioxidant Activity in the Leaves and Fruits of Chinese Olive (<i>Canarium album</i> (Lour.) DC.) CultivarsQingli Zhuang, Xin Tan, Peiwen Ma, et al.
Frontiers in Immunology|July 6, 2019
Circulating Myeloid Derived Suppressor Cells (MDSC) That Accumulate in Premalignancy Share Phenotypic and Functional Characteristics With MDSC in CancerPeiwen Ma, Pamela L Beatty, John McKolanis, et al.
Frontiers in Immunology|August 4, 2022
Clinical Investigations of CAR-T Cell Therapy for Solid TumorsKun Chen, Shuhang Wang, Dan Qi, et al.
Current Cancer Drug Targets|February 4, 2022
CEA-regulated Oncolytic Virus Anticancer Therapy: A Promising Strategy for Rare Solid TumorsYuqi Yang, Shuhang Wang, Peiwen Ma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 28, 2026
Intrathecal Allogeneic B7-H3-targeted CAR γδ T Cells for Leptomeningeal Metastasis from Solid Tumors: Safety, Efficacy, and Immunological Dynamics in a Phase 1 TrialPeiwen Ma, Yongxin Zhou, Weiwei Ma, et al.
Med (New York, N.Y.)|October 1, 2025
Antibody-drug conjugates: Current challenges and innovative solutions for precision cancer therapyXingyu Zhou, Yanjie Han, Yuan Fang, et al.
BMC Medicine|June 11, 2021
Perspectives of tumor-infiltrating lymphocyte treatment in solid tumorsShuhang Wang, Jingwei Sun, Kun Chen, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Heliyon|April 22, 2024
Pan-cancer analysis of polo-like kinase family genes reveals polo-like kinase 1 as a novel oncogene in kidney renal papillary cell carcinomaGuo Zhao, Yuning Wang, Jiawei Zhou, et al.
Cancer Letters|June 14, 2024
First report: PLATFORM study for precision treatment of rare tumors in ChinaJiawei Zhou, Peiwen Ma, Yale Jiang, et al.
Cancer Immunology, Immunotherapy : CII|July 6, 2026
Safety and feasibility of 5T4 antibody-coupled allogeneic NK cell therapy for solid tumors: a first-in-human phase 1 trialLiangjie Sun, Peiwen Ma, Zhenwei Miao, et al.
Food Science & Nutrition|October 27, 2025
Assessment of Essential Nutrients, Bioactive Compounds, and Antioxidant Activity in the Leaves and Fruits of Chinese Olive (<i>Canarium album</i> (Lour.) DC.) CultivarsQingli Zhuang, Xin Tan, Peiwen Ma, et al.
Frontiers in Immunology|July 6, 2019
Circulating Myeloid Derived Suppressor Cells (MDSC) That Accumulate in Premalignancy Share Phenotypic and Functional Characteristics With MDSC in CancerPeiwen Ma, Pamela L Beatty, John McKolanis, et al.
Frontiers in Immunology|August 4, 2022
Clinical Investigations of CAR-T Cell Therapy for Solid TumorsKun Chen, Shuhang Wang, Dan Qi, et al.
Current Cancer Drug Targets|February 4, 2022
CEA-regulated Oncolytic Virus Anticancer Therapy: A Promising Strategy for Rare Solid TumorsYuqi Yang, Shuhang Wang, Peiwen Ma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 28, 2026
Intrathecal Allogeneic B7-H3-targeted CAR γδ T Cells for Leptomeningeal Metastasis from Solid Tumors: Safety, Efficacy, and Immunological Dynamics in a Phase 1 TrialPeiwen Ma, Yongxin Zhou, Weiwei Ma, et al.
Med (New York, N.Y.)|October 1, 2025
Antibody-drug conjugates: Current challenges and innovative solutions for precision cancer therapyXingyu Zhou, Yanjie Han, Yuan Fang, et al.
BMC Medicine|June 11, 2021
Perspectives of tumor-infiltrating lymphocyte treatment in solid tumorsShuhang Wang, Jingwei Sun, Kun Chen, et al.
Pageof 3